Camilla Collina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Camilla Collina has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Barbara de Faria da Fonseca
Control of Chronic Viral Infections Group, Virus & Immunity Unit, Institut Pasteur, Université Paris Cité
1 shared publication - Delphine Planas
Virus and Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France
1 shared publication - Hippolyte Debarnot
Control of Chronic Viral Infections Group, Virus and Immunity Unit, Institut Pasteur, Université de Paris Cité, Centre National de la Recherche Scientifique UMR3569 1 , Paris, France
1 shared publication - Héloïse Mary
Universite Paris Cite
1 shared publication - Isabelle Staropoli
Virus and Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France
1 shared publication - Jerome Kervevan
Enterome, Paris, Île-de-France, France
1 shared publication
Latest Publications
- Open Access
- 6 September 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (10)
Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting
Predicting the immunogenicity of candidate vaccines in humans remains a challenge. To address this issue, we developed a lymphoid organ-chip (LO chip) model based on a microfluidic chip seeded with human PBMC at high density within a 3D collagen matrix. Perfusion of the SARS-CoV-2 spike protein mimicked a vaccine boost by inducing a massive amplification of spike-specific memory B cells, plasmablast differentiation, and spike-specific antibody secretion. Features of lymphoid tissue, including the formation of activated CD4+ T cell/B cell clusters and the emigration of matured plasmablasts, were recapitulated in the LO chip. Importantly, myeloid cells were competent at capturing and expressing mRNA vectored by lipid nanoparticles, enabling the assessment of responses to mRNA vaccines. Comparison of on-chip responses to Wuhan monovalent and Wuhan/Omicron bivalent mRNA vaccine boosts showed equivalent induction of Omicron neutralizing antibodies, pointing at immune imprinting as reported in vivo. The LO chip thus represents a versatile platform suited to the preclinical evaluation of vaccine-boosting strategies.
- 6 September 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (10)
Open AccessModeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting
Predicting the immunogenicity of candidate vaccines in humans remains a challenge. To address this issue, we developed a lymphoid organ-chip (LO chip) model based on a microfluidic chip seeded with human PBMC at high density within a 3D collagen matrix. Perfusion of the SARS-CoV-2 spike protein mimicked a vaccine boost by inducing a massive amplification of spike-specific memory B cells, plasmablast differentiation, and spike-specific antibody secretion. Features of lymphoid tissue, including the formation of activated CD4+ T cell/B cell clusters and the emigration of matured plasmablasts, were recapitulated in the LO chip. Importantly, myeloid cells were competent at capturing and expressing mRNA vectored by lipid nanoparticles, enabling the assessment of responses to mRNA vaccines. Comparison of on-chip responses to Wuhan monovalent and Wuhan/Omicron bivalent mRNA vaccine boosts showed equivalent induction of Omicron neutralizing antibodies, pointing at immune imprinting as reported in vivo. The LO chip thus represents a versatile platform suited to the preclinical evaluation of vaccine-boosting strategies.